Alessandra Gentilini - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

Alessandra Gentilini

Showing results (11-20 of 16) with videos related to

Pageof 2

Sort By:

You have reached the last page of results.This site can display upto 16 results.

Cells|March 7, 2020

Multifaceted Aspects of Metabolic Plasticity in Human Cholangiocarcinoma: An Overview of Current PerspectivesMirella Pastore, Giulia Lori, Alessandra Gentilini, et al.

Oncogenesis|October 24, 2019

The protein kinase CK2 contributes to the malignant phenotype of cholangiocarcinoma cellsGiovanni Di Maira, Alessandra Gentilini, Mirella Pastore, et al.

Gastroenterology|January 31, 2003

Antifibrogenic effects of canrenone, an antialdosteronic drug, on human hepatic stellate cellsAlessandra Caligiuri, Raffaella M s De Franco, Roberto G Romanelli, et al.

Journal of Hepatology|December 16, 2003

4-Hydroxynonenal as a selective pro-fibrogenic stimulus for activated human hepatic stellate cellsElena Zamara, Erica Novo, Fabio Marra, et al.

Biochimica Et Biophysica Acta. Molecular Basis of Disease|May 7, 2019

CXCR7 contributes to the aggressive phenotype of cholangiocarcinoma cellsAlessandra Gentilini, Alessandra Caligiuri, Chiara Raggi, et al.

Hepatology (Baltimore, Md.)|May 7, 2021

Extracellular Signal-Regulated Kinase 5 Regulates the Malignant Phenotype of Cholangiocarcinoma CellsAlessandra Gentilini, Giulia Lori, Alessandra Caligiuri, et al.

Pageof 2

Search research articles

Showing results (11-20 of 16) with videos related to

Sort By:

Pageof 2

You have reached the last page of results.This site can display upto 16 results.

Cells|March 7, 2020

Multifaceted Aspects of Metabolic Plasticity in Human Cholangiocarcinoma: An Overview of Current PerspectivesMirella Pastore, Giulia Lori, Alessandra Gentilini, et al.

Oncogenesis|October 24, 2019

The protein kinase CK2 contributes to the malignant phenotype of cholangiocarcinoma cellsGiovanni Di Maira, Alessandra Gentilini, Mirella Pastore, et al.

Gastroenterology|January 31, 2003

Antifibrogenic effects of canrenone, an antialdosteronic drug, on human hepatic stellate cellsAlessandra Caligiuri, Raffaella M s De Franco, Roberto G Romanelli, et al.

Journal of Hepatology|December 16, 2003

4-Hydroxynonenal as a selective pro-fibrogenic stimulus for activated human hepatic stellate cellsElena Zamara, Erica Novo, Fabio Marra, et al.

Biochimica Et Biophysica Acta. Molecular Basis of Disease|May 7, 2019

CXCR7 contributes to the aggressive phenotype of cholangiocarcinoma cellsAlessandra Gentilini, Alessandra Caligiuri, Chiara Raggi, et al.

Hepatology (Baltimore, Md.)|May 7, 2021

Extracellular Signal-Regulated Kinase 5 Regulates the Malignant Phenotype of Cholangiocarcinoma CellsAlessandra Gentilini, Giulia Lori, Alessandra Caligiuri, et al.

Pageof 2